Cidara Therapeutics Inc. (CDTX) NASDAQ
$12.71 (0.38) (-2.90%)
Market Cap: $1.16B
As of 05/15/24 04:00 PM EDT. Market closed.
Cidara Therapeutics Inc. (CDTX)
NASDAQ
$12.71
(0.38) (-2.90%)
Market Cap: $1.16B
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies. our first product candidate is cd101 iv, a potential once-weekly intravenous therapy being developed for the treatment and prevention of systemic fungal infections. our second ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Jeffrey Stein
Full Time Employees
81
CEO Compensation (Base)
$460,000
CEO Compensation (Total)
$1.82M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Jeffrey Stein
Full Time Employees
81
CEO Compensation (Base)
$460,000
CEO Compensation (Total)
$1.82M
URL
Address
6310 Nancy Ridge Dr Ste 101, California, San Diego, 92121-3209.
PRICE CHART FOR CIDARA THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$13.09
Days Range
$12.67 - $13.13
52 week range
$10 - $29.60
Volume
81
Avg. Volume (30 days)
99,780
Market Cap
$1.16B
Dividend Yield
-
P/E
(50.57)
Shares Outstanding
91,235,020
Open
-
Previous Close
$13.09
Days Range
$12.67 - $13.13
52 week range
$10 - $29.60
Volume
81
Avg. Volume (30 days)
99,780
Market Cap
$1.16B
Dividend Yield
-
P/E
(50.57)
Shares Outstanding
91,235,020
FINANCIAL STATEMENTS FOR CIDARA THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR CIDARA THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Stein Jeffrey | President & CEO | Mar 11, 2024 | Option Exercise | $0.69 | 56,692 | 39,117 | 1,153,693 | Mar 12, 2024, 09:48 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Mar 11, 2024 | Sale | $0.67 | 21,029 | 14,085 | 258,681 | Mar 12, 2024, 09:48 PM |
Sandison Taylor | Chief Medical Officer | Mar 11, 2024 | Sale | $0.67 | 20,662 | 13,839 | 347,095 | Mar 12, 2024, 09:47 PM |
Ward Shane | COO & CLO | Mar 11, 2024 | Sale | $0.67 | 20,473 | 13,713 | 198,770 | Mar 12, 2024, 09:46 PM |
Shah Preetam | CFO & CBO | Mar 11, 2024 | Sale | $0.67 | 18,931 | 12,680 | 227,210 | Mar 12, 2024, 09:45 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Sep 11, 2023 | Sale | $0.95 | 18,469 | 17,509 | 275,710 | Sep 13, 2023, 04:24 PM |
Sandison Taylor | Chief Medical Officer | Sep 11, 2023 | Sale | $0.95 | 18,793 | 17,810 | 363,757 | Sep 13, 2023, 04:22 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Aug 14, 2023 | Buy | $0.97 | 10,000 | 9,700 | 294,179 | Aug 14, 2023, 07:40 PM |
Stein Jeffrey | President & CEO | Aug 08, 2023 | Buy | $0.96 | 50,000 | 47,885 | 331,602 | Aug 08, 2023, 06:04 PM |
Stein Jeffrey | President & CEO | Mar 27, 2023 | Buy | $1.04 | 50,000 | 51,855 | 281,602 | Mar 27, 2023, 07:03 PM |
Ward Shane | COO & CLO | Mar 13, 2023 | Sale | $1.53 | 4,329 | 6,623 | 84,576 | Mar 13, 2023, 09:21 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Mar 13, 2023 | Sale | $1.53 | 7,562 | 11,570 | 190,179 | Mar 13, 2023, 09:21 PM |
Shah Preetam | CFO & CBO | Mar 13, 2023 | Sale | $1.53 | 6,648 | 10,171 | 148,141 | Mar 13, 2023, 09:20 PM |
Sandison Taylor | Chief Medical Officer | Mar 13, 2023 | Sale | $1.53 | 7,203 | 11,021 | 288,550 | Mar 13, 2023, 09:19 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Jan 12, 2023 | Sale | $1.20 | 11,814 | 14,177 | 1,484 | Jan 27, 2023, 04:33 PM |
Shah Preetam | CFO & CBO | Sep 19, 2022 | Sale | $0.77 | 15,642 | 12,035 | 150,789 | Sep 19, 2022, 08:28 PM |
Sandison Taylor | Chief Medical Officer | Sep 12, 2022 | Sale | $0.68 | 18,478 | 12,656 | 291,753 | Sep 13, 2022, 06:51 PM |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | Sep 12, 2022 | Sale | $0.68 | 18,159 | 12,437 | 193,741 | Sep 13, 2022, 06:48 PM |
Daruwala Paul | Chief Operating Officer | Sep 12, 2022 | Sale | $0.68 | 16,199 | 11,095 | 221,099 | Sep 13, 2022, 06:40 PM |
Shah Preetam | CFO & CBO | Mar 31, 2022 | Option Exercise | $0.83 | 24,820 | 20,601 | 112,431 | Apr 04, 2022, 05:21 PM |
Ward Shane | CHIEF LEGAL OFFICER | Mar 31, 2022 | Option Exercise | $0.83 | 23,122 | 19,191 | 80,905 | Apr 04, 2022, 05:12 PM |
Stein Jeffrey | President & CEO | Mar 31, 2022 | Option Exercise | $0.83 | 140,985 | 117,018 | 922,635 | Apr 04, 2022, 05:09 PM |
Johnson Brady | Vice President, Finance | Mar 21, 2022 | Sale | $0.81 | 654 | 530 | 49,366 | Mar 23, 2022, 06:11 PM |
Johnson Brady | Vice President, Finance | Mar 11, 2022 | Sale | $0.71 | 945 | 671 | 50,020 | Mar 11, 2022, 08:29 PM |
Daruwala Paul | Chief Operating Officer | Jan 05, 2022 | Sale | $1.25 | 5,133 | 6,416 | 187,298 | Jan 07, 2022, 08:26 PM |
Johnson Brady | Vice President, Finance | Jan 05, 2022 | Sale | $1.25 | 416 | 520 | 50,965 | Jan 07, 2022, 08:23 PM |
Tari Leslie | Chief Scientific Officer | Jan 05, 2022 | Sale | $1.25 | 1,252 | 1,565 | 155,400 | Jan 07, 2022, 08:20 PM |
Stein Jeffrey | President & CEO | Nov 12, 2021 | Buy | $1.59 | 50,000 | 79,530 | 465,878 | Nov 15, 2021, 06:41 PM |
Shah Preetam | CFO & CBO | Nov 12, 2021 | Buy | $1.54 | 20,000 | 30,800 | 20,000 | Nov 15, 2021, 06:38 PM |
Franson Timothy R | Director | Sep 13, 2021 | Buy | $2.12 | 7,000 | 14,823 | 11,000 | Sep 14, 2021, 07:59 PM |
Stein Jeffrey | President & CEO | Aug 19, 2021 | Buy | $1.79 | 10,000 | 17,871 | 415,878 | Aug 19, 2021, 04:24 PM |
Stein Jeffrey | President & CEO | Aug 18, 2021 | Buy | $1.72 | 40,000 | 68,884 | 405,878 | Aug 19, 2021, 04:24 PM |
Daruwala Paul | Chief Operating Officer | Apr 01, 2021 | Sale | $2.66 | 593 | 1,577 | 50,531 | Apr 05, 2021, 06:17 PM |
Daruwala Paul | Chief Operating Officer | Jan 05, 2021 | Sale | $2.06 | 2,868 | 5,908 | 49,724 | Apr 05, 2021, 06:17 PM |
Oien Jessica | General Counsel & Secretary | Jan 05, 2021 | Sale | $2.06 | 824 | 1,697 | 6,141 | Apr 05, 2021, 05:35 PM |
Oien Jessica | General Counsel & Secretary | Apr 01, 2021 | Sale | $2.66 | 1,177 | 3,131 | 7,764 | Apr 05, 2021, 05:35 PM |
Stein Jeffrey | President & CEO | Nov 10, 2020 | Buy | $2.00 | 50,000 | 100,015 | 347,878 | Nov 12, 2020, 06:00 AM |
Levine James E. | Chief Financial Officer | Nov 10, 2020 | Buy | $2.01 | 50,000 | 100,720 | 50,000 | Nov 12, 2020, 06:00 AM |
Abdollahian Neil | Chief Business Officer | Jan 03, 2020 | Sale | $3.42 | 940 | 3,215 | 50,308 | Jun 25, 2020, 08:03 PM |
Daruwala Paul | Chief Operating Officer | Jan 03, 2020 | Sale | $3.42 | 940 | 3,215 | 52,592 | Jun 25, 2020, 08:01 PM |
Levine James E. | Chief Financial Officer | Sep 24, 2019 | Buy | $1.91 | 30,000 | 57,240 | 30,000 | Mar 23, 2020, 07:12 PM |
Sandison Taylor | Chief Medical Officer | Feb 10, 2020 | Option Exercise | $2.51 | 6,115 | 15,349 | 73,331 | Feb 11, 2020, 06:46 PM |
Sandison Taylor | Chief Medical Officer | Feb 07, 2010 | Option Exercise | $2.51 | 4,594 | 11,531 | 67,216 | Feb 11, 2020, 06:46 PM |
Stein Jeffrey | President & CEO | Jan 29, 2020 | Option Exercise | $2.51 | 32,283 | 81,030 | 257,902 | Jan 30, 2020, 08:50 PM |
Stein Jeffrey | President & CEO | Jan 29, 2020 | Option Exercise | $2.51 | 7,558 | 18,971 | 293,878 | Jan 30, 2020, 08:50 PM |
Levine James E. | Chief Financial Officer | Jan 28, 2020 | Option Exercise | $2.51 | 6,891 | 17,296 | 211,891 | Jan 30, 2020, 08:49 PM |
Oien Jessica | General Counsel & Secretary | Jan 02, 2020 | Sale | $3.86 | 834 | 3,219 | 6,965 | Jan 06, 2020, 05:28 PM |
Abdollahian Neil | Chief Business Officer | Jan 03, 2020 | Sale | $3.42 | 2,340 | 8,003 | 51,248 | Jan 06, 2020, 05:27 PM |
Daruwala Paul | Chief Operating Officer | Jan 03, 2020 | Sale | $3.42 | 2,340 | 8,003 | 53,532 | Jan 06, 2020, 05:26 PM |
Daruwala Paul | Chief Operating Officer | Oct 02, 2019 | Sale | $1.88 | 3,295 | 6,195 | 55,872 | Oct 03, 2019, 09:15 PM |
Abdollahian Neil | Chief Business Officer | Oct 01, 2019 | Sale | $1.98 | 7,284 | 14,422 | 49,588 | Oct 03, 2019, 09:13 PM |
Oien Jessica | General Counsel & Secretary | Sep 27, 2019 | Sale | $1.86 | 1,001 | 1,862 | 7,799 | Oct 01, 2019, 05:07 PM |
Stein Jeffrey | President & CEO | Sep 24, 2019 | Buy | $1.91 | 52,500 | 100,102 | 225,619 | Sep 26, 2019, 09:23 PM |
Levine James E. | Chief Financial Officer | Sep 24, 2019 | Buy | $1.91 | 30,000 | 57,240 | 205,000 | Sep 26, 2019, 09:17 PM |
Abdollahian Neil | Chief Business Officer | Mar 08, 2019 | Sale | $2.44 | 2,300 | 5,612 | 30,472 | Mar 08, 2019, 07:30 PM |
Daruwala Paul | Chief Operating Officer | Mar 07, 2019 | Sale | $2.55 | 2,240 | 5,714 | 49,567 | Mar 08, 2019, 07:29 PM |
Stein Jeffrey | President & CEO | May 23, 2018 | Buy | $4.70 | 212,766 | 1,000,000 | 268,320 | May 24, 2018, 05:16 PM |
BIOTECH TARGET N V | 10% Owner | Nov 15, 2017 | Buy | $7.57 | 60,000 | 453,966 | 2,295,272 | Nov 16, 2017, 12:19 PM |
Stein Jeffrey | President & CEO | Sep 12, 2017 | Buy | $6.79 | 7,350 | 49,906 | 51,851 | Sep 12, 2017, 05:49 PM |
Sandison Taylor | Chief Medical Officer | Jun 07, 2017 | Buy | $5.90 | 19,344 | 114,130 | 25,695 | Jun 08, 2017, 04:40 PM |
Sandison Taylor | Chief Medical Officer | Jun 06, 2017 | Buy | $5.90 | 656 | 3,870 | 6,351 | Jun 08, 2017, 04:40 PM |
Stein Jeffrey | President & CEO | Jun 05, 2017 | Buy | $5.95 | 15,000 | 89,211 | 44,501 | Jun 07, 2017, 04:45 PM |
Stein Jeffrey | President & CEO | Mar 31, 2017 | Buy | $7.75 | 12,900 | 99,975 | 27,196 | Apr 04, 2017, 04:33 PM |
Forrest Kevin | COO & CFO | May 20, 2016 | Buy | $11.53 | 4,356 | 50,225 | 58,253 | May 23, 2016, 04:34 PM |
Stein Jeffrey | President & CEO | May 20, 2016 | Buy | $11.51 | 4,310 | 49,608 | 203,697 | May 23, 2016, 04:32 PM |
Stein Jeffrey | President & CEO | Nov 25, 2015 | Buy | $15.60 | 1,300 | 20,280 | 6,700 | Nov 27, 2015, 05:33 PM |
Stein Jeffrey | President & CEO | Nov 24, 2015 | Buy | $14.97 | 5,400 | 80,838 | 5,400 | Nov 27, 2015, 05:33 PM |
Forrest Kevin | COO & CFO | Nov 23, 2015 | Buy | $14.23 | 7,087 | 100,848 | 51,719 | Nov 23, 2015, 07:18 PM |
Heron Patrick J | Director | Apr 20, 2015 | Buy | $16.00 | 200,000 | 3,200,000 | 155,645 | Apr 22, 2015, 02:49 PM |
Kjellson Nina S | Director | Apr 20, 2015 | Buy | $16.00 | 200,000 | 3,200,000 | 200,000 | Apr 22, 2015, 02:45 PM |
Stein Jeffrey | President & CEO | Apr 20, 2015 | Buy | $16.00 | 420 | 6,720 | 420 | Apr 21, 2015, 03:35 PM |
PEREZ ROBERT J | Director | Apr 20, 2015 | Buy | $16.00 | 5,000 | 80,000 | 5,000 | Apr 21, 2015, 03:32 PM |
Franson Timothy R | Director | Apr 20, 2015 | Buy | $16.00 | 4,000 | 64,000 | 4,000 | Apr 21, 2015, 03:31 PM |
BURGESS DANIEL D | Director | Apr 20, 2015 | Buy | $16.00 | 3,000 | 48,000 | 3,000 | Apr 21, 2015, 03:29 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Stein Jeffrey | President & CEO | 03/11/2024 | 39,117 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 03/11/2024 | 14,085 |
Sandison Taylor | Chief Medical Officer | 03/11/2024 | 13,839 |
Ward Shane | COO & CLO | 03/11/2024 | 13,713 |
Shah Preetam | CFO & CBO | 03/11/2024 | 12,680 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 09/11/2023 | 17,509 |
Sandison Taylor | Chief Medical Officer | 09/11/2023 | 17,810 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 08/14/2023 | 9,700 |
Stein Jeffrey | President & CEO | 08/08/2023 | 47,885 |
Stein Jeffrey | President & CEO | 03/27/2023 | 51,855 |
Ward Shane | COO & CLO | 03/13/2023 | 6,623 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 03/13/2023 | 11,570 |
Shah Preetam | CFO & CBO | 03/13/2023 | 10,171 |
Sandison Taylor | Chief Medical Officer | 03/13/2023 | 11,021 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 01/12/2023 | 14,177 |
Shah Preetam | CFO & CBO | 09/19/2022 | 12,035 |
Sandison Taylor | Chief Medical Officer | 09/12/2022 | 12,656 |
Tari Leslie | CHIEF SCIENTIFIC OFFICER | 09/12/2022 | 12,437 |
Daruwala Paul | Chief Operating Officer | 09/12/2022 | 11,095 |
Shah Preetam | CFO & CBO | 03/31/2022 | 20,601 |
Ward Shane | CHIEF LEGAL OFFICER | 03/31/2022 | 19,191 |
Stein Jeffrey | President & CEO | 03/31/2022 | 117,018 |
Johnson Brady | Vice President, Finance | 03/21/2022 | 530 |
Johnson Brady | Vice President, Finance | 03/11/2022 | 671 |
Daruwala Paul | Chief Operating Officer | 01/05/2022 | 6,416 |
Johnson Brady | Vice President, Finance | 01/05/2022 | 520 |
Tari Leslie | Chief Scientific Officer | 01/05/2022 | 1,565 |
Stein Jeffrey | President & CEO | 11/12/2021 | 79,530 |
Shah Preetam | CFO & CBO | 11/12/2021 | 30,800 |
Franson Timothy R | Director | 09/13/2021 | 14,823 |
Stein Jeffrey | President & CEO | 08/19/2021 | 17,871 |
Stein Jeffrey | President & CEO | 08/18/2021 | 68,884 |
Daruwala Paul | Chief Operating Officer | 04/01/2021 | 1,577 |
Daruwala Paul | Chief Operating Officer | 01/05/2021 | 5,908 |
Oien Jessica | General Counsel & Secretary | 01/05/2021 | 1,697 |
Oien Jessica | General Counsel & Secretary | 04/01/2021 | 3,131 |
Stein Jeffrey | President & CEO | 11/10/2020 | 100,015 |
Levine James E. | Chief Financial Officer | 11/10/2020 | 100,720 |
Abdollahian Neil | Chief Business Officer | 01/03/2020 | 3,215 |
Daruwala Paul | Chief Operating Officer | 01/03/2020 | 3,215 |
Levine James E. | Chief Financial Officer | 09/24/2019 | 57,240 |
Sandison Taylor | Chief Medical Officer | 02/10/2020 | 15,349 |
Sandison Taylor | Chief Medical Officer | 02/07/2010 | 11,531 |
Stein Jeffrey | President & CEO | 01/29/2020 | 81,030 |
Stein Jeffrey | President & CEO | 01/29/2020 | 18,971 |
Levine James E. | Chief Financial Officer | 01/28/2020 | 17,296 |
Oien Jessica | General Counsel & Secretary | 01/02/2020 | 3,219 |
Abdollahian Neil | Chief Business Officer | 01/03/2020 | 8,003 |
Daruwala Paul | Chief Operating Officer | 01/03/2020 | 8,003 |
Daruwala Paul | Chief Operating Officer | 10/02/2019 | 6,195 |
Abdollahian Neil | Chief Business Officer | 10/01/2019 | 14,422 |
Oien Jessica | General Counsel & Secretary | 09/27/2019 | 1,862 |
Stein Jeffrey | President & CEO | 09/24/2019 | 100,102 |
Levine James E. | Chief Financial Officer | 09/24/2019 | 57,240 |
Abdollahian Neil | Chief Business Officer | 03/08/2019 | 5,612 |
Daruwala Paul | Chief Operating Officer | 03/07/2019 | 5,714 |
Stein Jeffrey | President & CEO | 05/23/2018 | 1,000,000 |
BIOTECH TARGET N V | 10% Owner | 11/15/2017 | 453,966 |
Stein Jeffrey | President & CEO | 09/12/2017 | 49,906 |
Sandison Taylor | Chief Medical Officer | 06/07/2017 | 114,130 |
Sandison Taylor | Chief Medical Officer | 06/06/2017 | 3,870 |
Stein Jeffrey | President & CEO | 06/05/2017 | 89,211 |
Stein Jeffrey | President & CEO | 03/31/2017 | 99,975 |
Forrest Kevin | COO & CFO | 05/20/2016 | 50,225 |
Stein Jeffrey | President & CEO | 05/20/2016 | 49,608 |
Stein Jeffrey | President & CEO | 11/25/2015 | 20,280 |
Stein Jeffrey | President & CEO | 11/24/2015 | 80,838 |
Forrest Kevin | COO & CFO | 11/23/2015 | 100,848 |
Heron Patrick J | Director | 04/20/2015 | 3,200,000 |
Kjellson Nina S | Director | 04/20/2015 | 3,200,000 |
Stein Jeffrey | President & CEO | 04/20/2015 | 6,720 |
PEREZ ROBERT J | Director | 04/20/2015 | 80,000 |
Franson Timothy R | Director | 04/20/2015 | 64,000 |
BURGESS DANIEL D | Director | 04/20/2015 | 48,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CIDARA THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 2,554,973 | 0.0037% | 41.77% | Other |
BLACKROCK INC. | 715,410 | 0.00002% | -23.74% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 838,286 | 0.00007% | 4.02% | Other |
CHANGE IN SHARES OUTSTANDING FOR CIDARA THERAPEUTICS INC
STOCK BUYBACKS FOR CIDARA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.28%
1Q
06/30/2023
0.47%
2Q
03/31/2023
-10.53%
3Q
12/31/2022
25.89%
4Q
09/30/2022
2.20%
5Q
06/30/2022
30.96%
6Q
03/31/2022
32.87%
7Q
12/31/2021
72.61%
8Q
09/30/2021
82.78%
9Q
06/30/2021
52.62%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CIDARA THERAPEUTICS INC
LOADING...